Please see below for a list of search results.
Faecal microbiota transplants (FMT) are recognised as an emerging treatment for recurrent Clostridium difficile infections in patients where antibiotic and other lines of treatment have failed.
HTA-licensed establishments in the post mortem sector are required to report incidents (HTARIs), and those in the human application and organ donation and transplantation sectors are required to report serious adverse events or reactions (SAEARs), as part of their licensing with us.
The Human Tissue Authority (HTA) welcomes the publication of the report from the Regenerative Medicine Expert Group, “Building on our own potential: a UK pathway for regenerative medicine”.
EU Directives are being put in place for the coding and import of tissues and cells for human application (HA). These will be transposed into UK law during 2016 and the process of writing the UK Regulations is underway.Copies of these Directives and an overview from the Department of Health (DH...
Issued March 2010 Umbilical cord blood (cord blood) is collected at the time of birth and stored so that it may be available for potential future treatment of the child or another person.
Please note that if you are not undertaking activities relating to material for human application, for example you carry out organ donation and transplantation, post mortems or anatomical examinations, this system is not applicable to you.
This guide explains the requirements for licences which store tissues and cells for human application and for licences and/or third party agreements which carry out the procurement, testing, processing, distribution, import or export of tissues and cells for human application.
CONSULTATION NOW CLOSED.
For more ifnromation, please see our current Codes of Practice and Standards